 |
Journal articles
Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications
Abstract : Obstructive sleep apnea (OSA) is now recognized as an independent and important risk factor for cardiovascular diseases such as hypertension, coronary heart disease, heart failure and stroke. Clinical and experimental data have confirmed that intermittent hypoxia is a major contributor to these deleterious consequences. The repetitive occurrence of hypoxia-reoxygenation sequences generates significant amounts of free radicals, particularly in moderate to severe OSA patients. Moreover, in addition to hypoxia, reactive oxygen species (ROS) are potential inducers of the hypoxia inducible transcription factor-1 (HIF-1) that promotes the transcription of numerous adaptive genes some of which being deleterious for the cardiovascular system, such as the endothelin-1 gene. This review will focus on the involvement of the ROS-HIF-1-endothelin signaling pathway in OSA and intermittent hypoxia and discuss current and potential therapeutic approaches targeting this pathway to treat or prevent cardiovascular disease in moderate to severe OSA patients.
Cited literature [6 references]
https://www.hal.inserm.fr/inserm-01369186
Contributor : Diane Godin-Ribuot Connect in order to contact the contributor
Submitted on : Tuesday, September 20, 2016 - 3:49:43 PM
Last modification on : Tuesday, May 11, 2021 - 11:36:32 AM
Contributor : Diane Godin-Ribuot Connect in order to contact the contributor
Submitted on : Tuesday, September 20, 2016 - 3:49:43 PM
Last modification on : Tuesday, May 11, 2021 - 11:36:32 AM
File
Belaidi et al. P&T 19052016 Re...
Files produced by the author(s)